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Abstract
Background: Essential hypertension is a chronic disease that can lead to stroke or death if
uncontrolled. It is both a global problem in the U.S. and the world.
Problem: A 10-day reflective practice revealed that the current practice of prescribing
amlodipine of 2.5mg to 10mg oral tablet daily or Losartan 25mg to 100mg oral tablet daily was
ineffective in managing essential hypertension in both newly diagnosed and established patients.
The review of the literature guided the selection of an evidence-based practice utilized in
implementing this project. The Academic Center for Evidence-Based Practice (ACE) Star Model
of Knowledge Transformation (Stevens, 2013) was used to transfer the acquired knowledge into
practice.
Design: For this quality improvement project, low doses of thiazides were prescribed as a
monotherapy or combination therapy for newly diagnosed or established patients with essential
hypertension utilizing the PDSA cycle.
Setting: This quality improvement project was implemented in a small primary care clinic with
male and female adult patients aged 44-65 years old.
Intervention: Chlorthalidone 12.5mg tablet to 25mg oral tablet daily or Hydrochlorothiazide
12.5mg to 25mg tablet oral daily was prescribed for newly diagnosed patients or added as an
adjunct therapy to established patients with uncontrolled blood pressure. A PDSA cycle guided
the implementation of the project for 4 weeks. A blood pressure log was given to the patient with
follow-up calls to ensure consistency.
Outcome: The follow-up assessment showed a reduction in the Systolic BP <140 mmHg and
Diastolic <90 mmHg. The project concluded that thiazides are effective as a monotherapy or
combination therapy to manage essential hypertension.
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Significance: The use of a quality improvement intervention has become an integral part of
nursing, especially for doctoral-prepared Advanced Practice Nurses (APRN). It enables the
DNP-prepared APRN to identify problems in a clinical practice setting with the knowledge to
intervene or solve the problem using quality improvement projects.
Keywords: essential hypertension, thiazides, ACE star model of knowledge
transformation, PDSA cycle
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Thiazides as a Monotherapy/Combination Therapy in Management of Essential
Hypertension
Introduction and Background
Essential hypertension is a chronic disease encountered in clinical settings. It is often
described as the silent killer and could lead to many risk factors such as stroke, cardiovascular
disease, kidney failure, and death when not controlled or managed. Unger et al. (2020) discussed
that elevated blood pressure had remained a leading cause of death globally, accounting for
about 10.4 million deaths per year (p. 2). Although essential]] hypertension can be easily
diagnosed and managed early, studies have shown that it affects almost 1 in 3 individuals in the
United States (Kaboli et al., 2018). Essential hypertension, also known as primary hypertension,
occurs when there is a rise in an adult’s blood pressure (BP) with no other disease condition.
This is a major health problem that can be managed with the right drug of choice. There are
evidence-based clinical practice guidelines used by clinicians in the management of essential
hypertension. Hypertension, although a global health problem, tends to be frequently
mismanaged in patients. Also, patients are faced with making frequent visits or calls to the clinic
due to ineffective control of their blood pressure. The problem of noncompliance to medication
originates when patients are prescribed multiple antihypertensive medications and they are not
getting the outcome or result of the therapy. The decision to choose the best possible
antihypertensive medication that is affordable and effective for the patient can be quite
challenging. As a doctorial prepared advanced practice nurse, identifying and solving a problem
with an evidence-based literature is the key in promoting quality health outcomes. For this
quality improvement project, the aim was to improve the management of essential hypertension
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with thiazides as a monotherapy or combination therapy. Uncontrolled essential hypertension is a
global health problem that can be easily overlooked, mismanaged, or undiagnosed.
Problem Description
This problem was identified during a 10-day reflective practice review in the clinic. The
review identified essential hypertension as a clinical issue that needs to be addressed. During the
10-day review, the usual practice of prescribing Amlodipine 2.5mg up to 10mg tablet 1 tablet PO
daily or Losartan 25mg up to 100mg tablet 1 tablet PO daily was ineffective. The patients were
seen more often than their routine scheduled visits with complaints of having uncontrolled blood
pressure. Reviewing the Electronic Health Record (EHR) showed that most of the patients
diagnosed with essential hypertension had systolic >140 mmHg and diastolic > 90mmHg. There
is absolutely a gap in knowledge in management of these patients. However, to close this gap, an
effective antihypertensive therapy was found based on current evidence available to lower blood
pressure at a systolic <140mmHg and diastolic < 90mmHg.
Available Knowledge
Kaboli et al. (2018) estimated that at least half of patients with hypertension in the nation
have uncontrolled blood pressure (p. 2). Studies have revealed that there are many strategies in
place to help improve the treatment of hypertension. Following these guidelines and adopting the
best suitable drug therapy will reduce the risks associated with uncontrolled blood pressure.
According to Wright and Musini (2018), the decision to choose a drug or medication to manage
elevated blood pressure needs to be made based on the “best available evidence on reduction of
the outcomes that are important to the patient” (p. 10). There is need to search for an evidencedbased literature showing an antihypertensive therapy that can effectively produce the desired
outcome of reducing the patient’s blood pressure. These outcomes are essential to both the
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clinician and the patients, knowing that uncontrolled essential hypertension can be very
detrimental to health. For example, it can lead to stroke, cardiovascular disease, and death. Also,
when a patients’ blood pressure is uncontrolled there will be a decrease in satisfaction, increased
risks associated with hypertension, cost problems, and noncompliance. Uncontrolled essential
hypertension leads to stroke, cardiovascular disease, and death. Patients are often educated on
prevention and promotion strategies that can help in controlling their blood pressures. Such
strategies include education on diet, stress, sedentary life, weight management, and correct
monitoring of blood pressure. Different studies and guidelines determine or discuss the best
effective drug therapy to manage essential hypertension. The evidence-based guidelines such as
the report by Joint National Committee (JNC) on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure (Arnett, et al., 2019) and the 2020 International Society of
Hypertension Global Hypertension Practice Guidelines (Unger, et al., 2020) recommended the
use of thiazides as a monotherapy or combination therapy in the management of essential
hypertension.
Rationale
The methodological framework utilized in planning this project was the model for
improvement (MFI). According to Harris, Roussel, Dearman, and Thomas (2018), the “model
for improvement provides a strong foundation and plan for any improvement effort or
intervention” (p. 162). Three questions were derived from this model as a guide for
implementation. The questions were: (a) What is one trying to accomplish? (b) How will I know
if there is an improvement with the change? (c) What changes do I need to make to see the
desired result? The PDSA (Plan-Do-Study-Act) cycle (Connelly, 2021) was used to plan and
evaluate the intervention. According to Connelly (2021), the PDSA model “offers a structured
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approach to experimental learning and to change evaluation” (p. 61). She further recommended
that the process should be described clearly on the use of the model in implementing the quality
improvement project.

Figure 1. Model for improvement (IHI, 2021).
The ACE Star Model of Knowledge Transformation
The translation of EBP into clinical practice is essential to ensure quality health care
outcomes and patient safety. White, Dudley-Brown, and Terhaar (2021) explained that “EBP in
healthcare today uses a formal process with specific criteria to appraise emerging evidence and
methods for incorporating that evidence to inform and change practice” (p. 4). Therefore, the
Academic Center for Evidence-Based Practice (ACE) star model of knowledge transformation
framework was used to effect the change at the clinic. The ACE Star model of knowledge
transformation is a framework developed by Kathleen Stevens to ensure the translation of
evidence-based knowledge into practice (White et al., 2021, p. 18). The processes of adopting
this model comprises of five steps. In step 1 (knowledge discovery), the gap in practice propelled
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the discovery of thiazides in the management of essential hypertension. Step 2 (evidence
summary) entailed the process of retrieving the EBP through literature reviews. In step 3
(translation into practice), the knowledge obtained was introduced into the clinical practice. In
step 4 (integration into practice), the intervention was implemented. In the final step (evaluation),
the outcome of the intervention was evaluated to support the aim and purpose of the project
(White et. al., 2021, p. 4).

Figure 2. The ACE Star Model of Knowledge Transformation (Stevens., 2013, p.4).
Specific Aims
This quality improvement project was conducted based on the clinic’s identified problem
to provide a better therapeutic strategy in managing essential hypertension. As a clinician, I
sought the best evidence-based practice available reflecting on many questions. The question
was, “What is the drug of choice or the best line of therapy to use in ensuring that the patient
maintains a systolic of <140 mmHg and diastolic <90 mmHg?” Identifying the gap in the
management of essential hypertension became the focus of this project. The clinical problem of
essential hypertension can affect any adult despite their economic status. This project aimed to
ensure that patients maintain a BP of systolic <140 mmHg and diastolic <90 mmHg, reduce risks
associated with uncontrolled BP, decrease cost for the patient, decrease infrequent office visits,
and increase in quality of life. Additionally, the clinic will have better patient care outcomes,
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increased patient-provider trust, and an opportunity for more new patients. If any of these goals
are not met, both patients and clinicians are dissatisfied.
Methods
The clinical practice problem was identified in a primary care practice setting with the
initiation of the project proceeded at Chinyere Awa MD Family Practice, a privately owned
primary care clinic located in southwest Houston, Texas. The staff includes an office manager, a
medical assistant, and a nurse practitioner student. The clinic serves mainly adults with some
pediatric patients. Most of the patients are from middle-/low-income status and depend on
transportation to come to the clinic. The population is underserved and consists of insured and
uninsured patients. The people considered for this project were male and female adult patients
aged 18 to 99. The practice setting strives to offer family care, laboratory, women’s health,
disease management, and health education.
Interventions
Over 10 days, all patients were seen and treated for their different chief complaints in the
clinic. Patients’ data were recorded and compared in the EHR. The review showed frequent
occurrences of patients coming in with complaints of uncontrolled blood pressure more than any
other disease condition. Patients with essential hypertension were given amlodipine from 2.5 up
to 10mg tab PO daily or losartan 25mg to 100mg tablet PO daily. Also, the patients were
educated on dietary modifications, exercise, and weight management. My current practice was
ineffective, as patients were frequently seen with complaints, fear, and frustrations of not
controlling their blood pressure. The ranges were systolic of >140 mmHg and diastolic of >90
mmHg at home and in the clinic. The question became, “What other possible therapeutic strategy
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can one use to maintain a patient’s blood pressure at a systolic <140 mmHg and diastolic <90
mmHg?”
This problem led to developing a PICOT question to help determine the best intervention
to effect the change. A literature review was conducted to determine the best possible
intervention appropriate for the PICOT question. Different searches were conducted through
various search engines such as Cochrane review, PubMed, CINAHL, OVID full text, and Google
Scholar. The mesh words were hypertension, essential hypertension, best drug treatment of
hypertension, drug therapy, and antihypertensive medications. In the article review, the goal was
to choose the three highest levels that support the intervention. The first literature was a level 12
Cochrane systematic review of randomized control trials from 1947 up to November 2017 to
determine the best choice of drug for hypertension (Wright & Musini, 2018). The study was on
comparing six different antihypertensive drug classes with “a placebo or no treatment in adult
patients with blood pressure over 140/90 mmHg” (Wright & Musini., 2018, p.1). The outcome
of the study revealed that first-line low-dose thiazides reduced the patient’s systolic and diastolic
blood pressure. The second literature, a level 9 12-week double-blind, randomized control trial,
assessed the efficacy of the use of indapamide sustained release/ amlodipine single-pill
combination in mild to moderate hypertensive (Dominiczak, de Chamvallins, BrzozowskaVillatte, & Asmar, 2019). The study confirmed a reduction of blood pressure <140/90 mmHg.
The third literature, a level 9, was a randomized control trial. The research was conducted to
depict if a low dose triple pressure therapy compared to usual care for adults with hypertension
needing monotherapy or combination therapy would be effective (Webster et al., 2018). The
literature supports the achievement of the target goal of <140 mmHg and <90 mmHg. Choosing
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a level 12 literature was a guide in answering the intervention question of the PICOT question to
address the clinical site needs. The PICOT question that guided this project was:
P: Newly diagnosed and established adult patients with essential hypertension
I: Prescribed thiazides as a monotherapy/combination therapy (proven by EBP
literature)
C: Amlodipine 2.5mg to 10mg 1 tab PO daily or Losartan 25 to 100mg tab PO daily
O: Systolic BP <140 mmHg and Diastolic BP <90 mmHg
T: 30 days (4 weeks)
This led to developing a quality improvement proposal project approved by my worksite
supervisor, DNP chair, and co-chair at the School of Nursing in the University of Texas at El
Paso (UTEP). An Institutional Review Board (IRB) training and application were submitted and
approved by the University IRB. The procurement of a project proposal, work letter, and an IRB
permitted the implementation of the project. The following outlines were utilized in
implementing this project from 02/08/21:
Week 1
1. Met and explained project to office staff, reinforced teaching on Office BP measurements
to Medical Assistants.
2. Inclusion Criteria:
a.

Newly diagnosed patients with essential hypertension

b.

Patients with uncontrolled essential hypertension already on antihypertensive
medication to receive thiazide as a combination therapy

3. Patient educated on blood pressure management
4. Followed up on patients with Blood pressure (BP) logs
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The above steps were repeated for 4 weeks with the exclusion of step 1.
Measures
The Plan-Do-Study-Act (PDSA) cycle was initiated with each patient intervention to
determine the outcome of the intervention. The planning phase consisted of identifying of the
problem, explaining the project to the work supervisor, and educating and instructing the office
manager, NP student, and medical assistant on the quality improvement project. In the second
phase, the DO, patients were prescribed thiazide as a combination therapy. In the third phase of
the study, the patients were followed up with a BP log and in the office to record data in the
EHR. The last phase, Act, which determined the outcome of the intervention as successful. Each
patient was involved in only one PDSA cycle, proving the success of the intervention.
The blood pressure log used in this project was from the American Heart Association
(AHA). The log contains instructions for patients on how to measure their blood pressure with
the frequency.
Also, the use of SQUIRE (Standards for Quality Improvement Reporting Excellence)
provided a guideline in writing this quality improvement project paper. According to Goodman,
et al. (2016), “the purpose of this guideline is to assist authors in writing clearly, precisely and
completely about systematic efforts to improve the quality, safety, and value of healthcare
services” (p. 1). Also, “the SQUIRE 2.0 explicitly emphasizes the importance of articulating a
rationale for proposed changes and describing the role of context, allowing authors and readers
to determine the generalizability of the Quality Improvement approach to other settings”
(McQuillian & Wong., 2016, p. 771).
Ethical Considerations
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This quality improvement project took place in a family practice clinical setting. The
inclusion criteria were for newly diagnosed patients with essential hypertension and established
patients diagnosed with essential hypertension already on antihypertensive medication who can
receive thiazides as an adjunct. Patients’ data were recorded in a secured EHR. There was no
audio or video record of this project. Also, since medications have side effects, patients were
instructed on the medication’s side effects or adverse effects. Patients were given educational
material on the medication and the expected side effects with instruction to discontinue
medication if any side effects or adverse effects are experienced. No patient identifiers were
released to anyone except the project manager. The UTEP IRB deemed this study was not a
research project before proceeding with the project.
Results
During the project, Chlorthalidone 12.5mg tablet was prescribed as a combination
therapy to one patient, while Hydrochlorothiazide 12.5mg was prescribed as combination
therapy to four patients with uncontrolled essential hypertension.
Patient 1
Currently, on Losartan 50mg tab PO daily, this patient is 60-year-old African American
female and was first seen on 2/23/21 with a complaint of systolic BP >140 mmHg and diastolic
>90 mmHg. Office BP was 145/85. Chlorthalidone 12.5mg tablet daily was added as a
combination with the Losartan decreased to 25mg tablet. The patient was given a BP log to keep
at home with a follow-up visit in the office on 3/10/21. The BP log showed decreased BP of
systolic < 140 mmHg and diastolic < 90 mmHg. The office BP was 125/77, and the patient
reported no side effects meeting the intended outcome.
Patient 2
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This patient, a 52-year-old Hispanic male, was seen on 2/26/21 with a BP of 160/90 but
was placed on Losartan 50mg/HCTZ 12.5mg tablet PO daily on 3/5/21 after confirming the
diagnosis. The patient’s blood pressure log showed a BP of 129/88 on 3/15/21 in the evening,
indicating a reduction in systolic < 140 mmHg and diastolic < 90 mmHg. The patient was
scheduled to be followed up on 3/19/21.
Patient 3
This patient, a 55-year-old Hispanic male, was seen on 3/1/21 and placed on Lisinopril
20mg/HCTZ 12.5mg tablet PO daily to be followed up in 2 weeks. The patient never returned to
the clinic despite frequent calls until the end of the project. No outcome was recorded.
Patient 4
This patient, a 44-year-old African American male, was seen on 3/15/21with a BP of
152/106 and placed on Losartan 50mg/HCTZ 12.5mg to be followed up in 2 weeks.
Patient 5
This patient, 68-year-old Asian female, was seen on 3/15/21 with a BP of 194/105 and
placed on Losartan 50mg/HCTZ 12.5mg 1 tablet PO daily to be followed up in 2 weeks.
Discussion
Summary
The project was extended by 1 week due to inclement weather in the week of 2/15/21 –
2/19/21 affecting the closure of the clinic for loss of power. This project was supposed to end on
3/6/21, but it was concluded on 3/15/21. Also, the project outcome was not obtained from two
patients. The two patients seen on 3/15/21 were to be followed up on 3/30/21. One patient never
returned to the clinic. Another challenge encountered during this project was the inability to

17
prescribe thiazide as a monotherapy for any patient. However, the outcome of the two patients
successfully supports the result of this project.
Analysis
Five patients met the criteria in this project. There were two females and three males with
the age range of 44 to 68 years old. Two were African American male and female, one was an
Asian female, and two were Hispanic males. No White was included in this study. Each patient
had a previous diagnosis of elevated blood pressure but uncontrolled. The outcome of patient 1
and 2 confirms that thiazides can be used as a combination therapy in patients with essential
hypertension to ensure a systolic of <140 mmHg and diastolic of <90 mmHg. The outcome of
the projects supports the evidence-based practice literature utilized in this quality improvement
project.
Limitations
The limitations of this project were the number of patients seen due to the clinic being a
small private clinic in an underserved population. The setback on the project timeline due to
inclement weather was another limitation. However, it was only limited to patients diagnosed
with essential hypertension with no complicated underlying condition.
Conclusions
Essential hypertension, when not controlled or managed, can be detrimental to an
individual’s health, leading to risks such as stroke, decreased quality of life, cardiovascular
disease, and death. The reduction of the systolic <140 mmHg and diastolic < 90 mmHg in these
two patients seen during this project supports the intervention for the use of thiazides as a
combination therapy in the management of essential hypertension.
Implications for Practice
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The doctoral-prepared nurse strives to promote a better patient health outcome and safety
by adopting the eight Doctor of Nursing Practice (DNP) essentials. The knowledge acquired
enables the doctoral-prepared clinical nurse to carry out a quality improvement project based on
the clinical needs’ assessment identified. The impact of this quality improvement project on the
patients includes:


Systolic BP <140 mmHg and diastolic <90 mmHg



Reduced risk factors associated with uncontrolled blood pressure



Decreased infrequent office visits



Cost-effective



Increased quality of life

The impact on the clinical site includes:


Better patient care outcome



Increase in patient-provider trust



Patient satisfaction



Fewer return visit



Opportunity for more new patients



Cost-effective

Therefore, this quality improvement project aimed to support the evidence-based practice
of prescribing thiazides as a combination therapy in managing patients with essential
hypertension in any clinical setting.
Funding
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https://usmlematerials.net/diuretics-drugs-in-treatment-hypertension/
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㻯㼔㼕㼚㼛㼚㼥㼑㻌㻻㼚㼡㼏㼔㼡㼗㼣㼡㻙㻭㼦㼡㼛㼚㼥㼑㻘㻌㻹㻿㻺㻘㻌㻭㻼㻾㻺㻘㻌㻲㻺㻼㻙㻯

DNħµǊŷȕŗ^
Essential hypertension is a chronic disease that
can lead to stroke or death if uncontrolled. It is
both a global problem in the U.S. and the world.

FRAMEWORK
(ACE STAR MODEL)

ƻǊŷDĵrō
A 10-day reflective practice revealed that the
current practice of prescribing amlodipine of
2.5mg to 10mg oral tablet daily or Losartan
25mg to 100mg oral tablet daily was ineffective
in managing essential hypertension in both
newly diagnosed and established patients. The
review of the literature guided the selection of
an evidence-based practice utilized in
implementing this project. The Academic
Center for Evidence-Based Practice (ACE) Star
Model of Knowledge Transformation helped
translate the research into practice.

ÝŗǻrǊərŗǻÝŷŗ

ŷȕǻNŷōr
The follow-up assessment showed a reduction
in the Systolic BP <140 mmHg and Diastolic <90
mmHg. The project concluded that thiazides are
effective as a monotherapy or combination
therapy to manage essential hypertension.

Chlorthalidone 12.5mg tablet to 25mg oral tablet daily
or Hydrochlorothiazide 12.5mg to 25mg tablet oral daily
was prescribed for newly diagnosed patients or added
as an adjunct therapy to established patients with
uncontrolled blood pressure. A PDSA cycle guided the
implementation of the project for 4 weeks. A blood
pressure log was given to the patient with follow-up
calls to ensure consistency.

ǢÝµŗÝ®ÝNŗNr
The use of a quality improvement intervention
has become an integral part of nursing,
especially for doctoral-prepared Advanced
Practice Nurses (APRN). It enables the DNPprepared APRN to identify problems in a
clinical practice setting with the knowledge to
intervene or solve the problem using quality
improvement projects.

DESIGN
For this quality improvement project, low
doses of thiazides were prescribed as a
monotherapy or combination therapy for
newly diagnosed or established patients
with essential hypertension utilizing the
PDSA cycle

ƻÝNŷǻǆȕrǢǻÝŷŗ

IMPLICATION FOR PRACTICE
PATIENTS

P- Newly diagnosed and established adult
patients with essential hypertension

ÝōµrDŷɭ

I- Prescribed thiazides as a monotherapy/
combination therapy proven by EBP Literature)
C- Amlodipine 2.5mg to 10mg 1 tab PO daily or
Losartan 25 to 100mg tab PO daily

This Photo by Unknown Author is licensed under CC BY-SA

O- Systolic BP <140 mm Hg and Diastolic <90
mmHg
T- 30 days (4 weeks)

• Systolic BP< 140 mmHg and Diastolic < 90 mmHg
• Reduced risk factors associated with uncontrolled
blood pressure
• Decreased in frequent office visits
• Cost-effective
• Increased quality of life
CLINICAL SETTING

ACE STAR MODEL
SETTING:

ÝōµrDŷɭ

This quality improvement project was implemented in
a small primary care clinic with male and female adult
patients aged 44-65 years old.

•
•
•
•
•
•

Better Patient care outcome
Increase in patient-provider trust
Patient satisfaction
Fewer return visit
Opportunity for more new patients
Cost effective
References

Stevens, K. R. (2013). The impact of evidence-based practice in nursing and the next big ideas. Online Journal of Issues
in Nursing, 18(2), 4. doi:10.3912/OJIN.Vol18No02Man04
Wright, J. M., Musini, V. M., & Gill, R. (2018). First-line drugs for hypertension. Cochrane Database of Systematic Reviews, (4)
doi:10.1002/14651858.CD001841.pub3
This Photo by Unknown Author is licensed under CC BY-SA

American Heart Association. (2020). My Blood Pressure Log. Retrieved from https://www.heart.org/-/media/files/healthtopics/high-blood-pressure/my-blood-pressure-log.pdf
White, K. M., Dudley-Brown, S., & Terhaar, M. F. (2021). Translation of evidence into nursing and health care practice (3rd ed.). New
York: Springer.
Connelly, L. M. (2021). Using the PDSA model correctly. MEDSURG Nursing, 30(1), 61–64.

